Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

CD34+CXCR4(CD184)+ Cells Differentiate Into Myeloid Dendritic Cell Progenitors

Robert E. Donahue, Ping Jin, Naoya Uchida, MD, PhD, Aylin C. Bonifacino, Yu Tian, Johanna I. Klinman, Joseph J Mattapallil, Mark E. Metzger, Ann Williams, Daniela Malide, John F. Tisdale, MD, David Stroncek, MD

Blood (2013) 122 (21): 4835.

https://doi.org/10.1182/blood.V122.21.4835.4835

Published: 2013

Journal Articles

Both Naïve and Memory T-Cell Subsets Participate in Alloresponses to HLA-Mismatched Targets – Implications for Adoptive Transfer of Viral Antigen-Specific T Cells.

J. Joseph Melenhorst, Ph.D., Phillip Scheinberg, MD, Ann Williams, Keyvan Keyvanfar, Melody Smith, J. Philip McCoy, Jr., PhD, Nancy F. Hensel, A. John Barrett, MD

Blood (2009) 114 (22): 2439.

https://doi.org/10.1182/blood.V114.22.2439.2439

Published: 2009

Journal Articles

Lentiviral Transduction of Ex Vivo Expanded Natural Killer Cells with a CD19 Chimeric Antigen Receptor Induces Cytotoxicity against Resistant B Cell Malignancies

Muthalagu Ramanathan, Su Su, Andreas Lundqvist, Maria Berg, Aleah Smith, Rebecca Lopez, Ann Williams, Erkut Bahceci, J. Philip McCoy, Laurent Boissel, Hans-Georg Klingemann, Richard Childs

Blood (2008) 112 (11): 3540.

https://doi.org/10.1182/blood.V112.11.3540.3540

Published: 2008

Journal Articles

Gene Dosage of the Cell Cycle Regulatory Phosphatases Cdc25C and PP2A Determines Sensitivity to Lenalidomide in del(5q) MDS.

Sheng Wei, MD, Kathy Rocha, BS, Ann Williams, Ph.D., Xianhong Chen, Ph.D, P.K. Burnette, Ph.D., Julie Y. Djeu, Ph.D., Qing Liu, Ph.D., John Byrd, M.D., Lubomir Sokol, M.D., Nick Lawrence, Ph.D., Roberta Pireddu, Ph.D, Gordon Dewald, Ph.D., Jaroslaw Maciejewski, M.D., Alan List, M.D.

Blood (2007) 110 (11): 118.

https://doi.org/10.1182/blood.V110.11.118.118

Published: 2007

Journal Articles

Lenalidomide (CC-5013; Revlimid®) Promotes Erythropoiesis in Myelodysplastic Syndromes (MDS) by CD45 Protein Tyrosine Phosphatase (PTP) Inhibition.

Alan F. List, MD, Myka Estes, Ann Williams, Ph.D., Madhavi Sekharam, Ph.D., Ukiyasu Ozawa, Ph.D., Gui Gao, M.D., Ph.D., Jerry Wu, Ph.D., Gui Gao, M.D., Ph.D., Lubomir Sokol, M.D., Ph.D.

Blood (2006) 108 (11): 1360.

https://doi.org/10.1182/blood.V108.11.1360.1360

Published: 2006

NARROW

CD34+CXCR4(CD184)+ Cells Differentiate Into Myeloid Dendritic Cell Progenitors

Both Naïve and Memory T-Cell Subsets Participate in Alloresponses to HLA-Mismatched Targets – Implications for Adoptive Transfer of Viral Antigen-Specific T Cells.

Lentiviral Transduction of Ex Vivo Expanded Natural Killer Cells with a CD19 Chimeric Antigen Receptor Induces Cytotoxicity against Resistant B Cell Malignancies

Gene Dosage of the Cell Cycle Regulatory Phosphatases Cdc25C and PP2A Determines Sensitivity to Lenalidomide in del(5q) MDS.

Lenalidomide (CC-5013; Revlimid®) Promotes Erythropoiesis in Myelodysplastic Syndromes (MDS) by CD45 Protein Tyrosine Phosphatase (PTP) Inhibition.

Email alerts

ASH Publications

American Society of Hematology

CD34+CXCR4(CD184)+ Cells Differentiate Into Myeloid Dendritic Cell Progenitors

Both Naïve and Memory T-Cell Subsets Participate in Alloresponses to HLA-Mismatched Targets – Implications for Adoptive Transfer of Viral Antigen-Specific T Cells.

Lentiviral Transduction of Ex Vivo Expanded Natural Killer Cells with a CD19 Chimeric Antigen Receptor Induces Cytotoxicity against Resistant B Cell Malignancies

Gene Dosage of the Cell Cycle Regulatory Phosphatases Cdc25C and PP2A Determines Sensitivity to Lenalidomide in del(5q) MDS.

Lenalidomide (CC-5013; Revlimid®) Promotes Erythropoiesis in Myelodysplastic Syndromes (MDS) by CD45 Protein Tyrosine Phosphatase (PTP) Inhibition.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only